-
-
-
-
-
-
-
Oppenheimer Downgrades Engene Holdings Inc. (ENGN) to Perform
-
-
-
-
-
-
-
Engene Holdings Inc. (ENGN) PT Lowered to $27 at Guggenheim
-
-
-
-
-
-
-
enGene completes LEGEND trial enrollment with 62% response rate, reports FY results
-
-
-
-
-
-
-
enGene reports 62% response rate for bladder cancer treatment
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Engene Holdings Inc. (ENGN)
-
-
-
-
-
-
-
Piper Sandler Starts Engene Holdings Inc. (ENGN) at Overweight
-
-
-
-
-
-
-
Engene Holdings Inc. (ENGN) PT Lowered to $17 at Leerink Partners
-
416,789 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

